Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
about
Energy metabolism in neuroblastoma and Wilms tumorIs Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshopTemporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onsetWT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.Stratification of Wilms tumor by genetic and epigenetic analysisUnusual association of non-anaplastic Wilms tumor and Cornelia de Lange syndrome: case report.Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1.Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumoursWnt signaling in kidney development and disease.Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.Wilms' tumor 1 gene (WT1) is overexpressed and provides an oncogenic function in pediatric nephroblastomas harboring the wild-type WT1Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation.The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour.Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
P2860
Q26770341-D9C2770F-34FB-4C46-A0AA-0BAB8E732AE7Q26829595-5419317D-2ACE-40E8-B710-27FFD0F28054Q34065557-E21984DF-9A78-44B5-B896-6CAD3D4BB37BQ34667826-7815091D-8F7F-4E8B-A0AF-1659F3FDBF3BQ35095712-3AD09487-11FD-4D39-9270-A3DAA97260E7Q35987087-43ACCFD5-775A-4434-98F5-1DFF3D0D03C2Q36049645-7208C4A6-74B5-4D7C-B6A5-E8F04D26B61CQ36200428-03D8477E-F8E2-4B80-9994-C1AE760A9ACCQ37256912-AF3C9D21-BCAD-4CA9-83A2-F0BB8769BD9EQ37367712-26C5569B-069F-4724-BEAA-127845DE771CQ37412944-6A148C83-5392-4EE3-AA3A-415C9732E506Q37437735-17A3CF0F-4748-4F54-906B-A5D05088272DQ39747265-4C965F96-0D34-423B-BD0E-131813E52C66Q39955939-9A6DD069-483C-435D-849A-03CCABA541FFQ41809711-A8943311-9F9B-4F82-BF4F-443C93040202Q42323762-53D8655B-E91C-4430-BC8A-07D18537BD44Q42550921-B7B1BF40-AC51-4C2F-9BAC-B7D0E0379DCDQ42685351-589F165F-404B-4C0E-8277-2879F1A5314BQ51739895-F785ECC4-CA3B-40D9-A575-A0B38A5EDB44
P2860
Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@en
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@nl
type
label
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@en
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@nl
prefLabel
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@en
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@nl
P2093
P1476
Myogenesis in Wilms' tumors is ...... and the Wnt signaling pathway.
@en
P2093
Anthony E Reeve
Kankatsu Yun
Makoto Sano
Rosemary W Heathcott
Ryuji Fukuzawa
P2888
P304
P356
10.1007/S10024-003-3023-8
P577
2004-03-04T00:00:00Z